Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Solid Tumor Testing Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, the market size for solid tumor testing has witnessed robust growth. From 2024 to 2025, the market is projected to increase from $27.96 billion to $29.94 billion, indicating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the historic period include the rise of personalized or precision medicine, ineffective tumor-selective drug delivery, the lack of therapeutic efficacy, unsustainable expenses, and reductive strategies towards cancer chemotherapies.

The market for solid tumor testing is projected to experience significant expansion in the coming years, with a predicted value of $39.95 billion in 2029, reflecting a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this anticipated growth include a higher incidence of cancer, improved healthcare facilities, the introduction of AI and IoT-based diagnostic tools, along with increasing government initiatives. Noteworthy trends for the forecast period encompass progress in diagnostic devices, the arrival of therapies using nanocarriers, strategic partnerships, and the development of next-generation testing equipment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp

What are the Fundamental Drivers and Innovations Shaping the Solid Tumor Testing Market?

The escalating rates of cancer are anticipated to fuel the expansion of the solid tumor testing market. Cancer is a disease characterized by abnormal cell growth and proliferation in the body. These irregular cells, referred to as cancer cells, have the potential to infiltrate nearby tissues and organs, and sometimes can even migrate to other bodily parts via the bloodstream or lymphatic system. Nearly 90% of cancers in adults are solid tumors. Solid tumor testing is utilized to identify cancer cells in the bloodstream of patients with solid tumors, even before the cancer can be detected through imaging tests. For example, a report from the Centers for Disease Control and Prevention, a national public health organization based in the US, revealed that in June 2023, there were 1,603,844 new cancer incidences and 602,347 cancer-induced fatalities in the US in 2020, with 403 fresh cancer diagnoses and 144 cancer-linked fatalities reported per 100,000 individuals. Hence, the rising incidence of cancer is boosting the growth of the solid tumor testing market.

How Is the Solid Tumor Testing Market Segmented?

The solid tumor testingmarket covered in this report is segmented –

1) By Type: Genetic Testing; Conventional Testing

2) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Cervical Cancer

3) By Application: Clinical; Research

4) By End-Users: Hospitals; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic Research Institutions

Subsegments:

1) By Genetic Testing: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescence In Situ Hybridization (FISH)

2) By Conventional Testing: Histopathology; Cytology; Imaging Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12658&type=smp

Which Regions Are Driving the Next Phase of the Solid Tumor Testing Market Growth?

North America was the largest region in the solid tumor testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Solid Tumor Testing Market?

Creative liquid biopsy test solutions are emerging as a significant trend in the solid tumor testing market. Major companies in this market are concentrating on developing these innovative solutions to enhance their market position and secure a competitive edge. For example, NeoGenomics Inc., a US-based testing lab, rolled out a comprehensive set of three liquid biopsy tests for solid tumor in June 2020. These cutting-edge tests are formulated to identify cancer cells in patients’ blood, even before these tumors are detectable in imaging tests. These tests aid healthcare professionals in choosing further tests or treatments. The benefits of these tests include non-invasiveness, early detection, tailor-made treatment plans, and they also have FDA approval. Additionally, with a turnaround time of seven days or less, these three new tests save a substantial amount of time for doctors.

View the full report here:

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

How Is the Solid Tumor Testing Market Defined and What Are Its Core Parameters?

Solid tumor testing refers to the diagnostic and molecular testing conducted on solid tumors, which are masses or growths of abnormal cells that form in various body tissues. Solid tumor testing is used to detect cancer cells or cancer-related DNA in patients’ blood with solid tumors, even if the cancer is not yet visible on imaging tests.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12658

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model